The role of Tau protein in the PTEN/PI3K/AKT pathway has been poorly explored in cancers [169,170,171], and at most it has been reported that Tau expression is inversely correlated to PTEN mutation/deletion in various cancers including gliomas [65]. This evidence concerns the gene AKT1 and cancer.